DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC – Zentalis Pharmaceuticals, Inc. Transaction History
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio value:
$39.52M
portfolio value
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC quarter portfolio value change:
-22.92%
quarter
Zentalis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -11.75M | $21.66 | 1.82M | |
| Q2 2022 | share | Increase | 0.00% | 1.82M shares | 51.27M | $28.1 | 1.82M |